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A B S T R A C T
Pesticide formulations typically contain adjuvants added to enhance the performance of the active ingredient.
Adjuvants may modify the bioavailability and toxicity of pesticides. In this study, the aim was to examine to
which degree nonylphenol (NP) may interfere with the toxicity of two organophosphorus pesticides found in
aquafeeds, chlorpyrifos-methyl (CPM) and pirimiphos-methyl (PPM). Atlantic salmon liver cells were exposed to
these compounds singly or in combinations for 48 h using 3D cell cultures. Cytotoxicity, gene expression (RT-
qPCR), and lipidomics endpoints were used to assess toxicity. The dose-response assessment showed that NP was
the most toxic compound at equimolar concentrations (100 μM). Shotgun lipidomics pointed to a general pattern
of elevated levels of saturated 18:0 fatty acids and declined levels of 18:1 monounsaturated fatty acids by the
combined treatment. All three compounds had a distinct effect on membrane phospholipids, in particular on
phosphatidylcholine (PC) and phosphatidylethanolamine (PE). Lipid species patterns predicted inhibited
stearoyl CoA desaturase (SCD) activity and increased Δ6 desaturase (D6D) activity in co-treated cells. While all
three compounds alone mitigated increased triacylglycerol (TAG) accumulation, combined treatment resulted in
lower total TAG in the cells. Multivariate analysis with PLS regression showed significant combined effects for
nine genes (d5d, d6d, scd, srebf2, vtg, esr1, cyp1, ugt1a, and cat) and four lipid species (FFA 22:5, LPC 18:0,
TAG52:1-FA16:0, and TAG52:1-FA18:0). In summary, this study demonstrates that the adjuvant can be the main
contributor to the toxicity of a mixture of two organophosphorus pesticides with relatively low toxicity in fish
cells.
1. Introduction
Feed safety risk assessment is traditionally done on a contaminant-
by-contaminant basis, potentially underestimating toxicity of chemical
mixtures [1]. Mixture toxicity might be greater-than-additive (sy-
nergistic interaction) or less-than-additive (antagonistic interaction),
and the outcome is often hard to predict. Dose addition is the most
common way to examine the mixture toxicity of combinations of con-
taminants [1]. This concept is however not always valid when mixtures
are composed of contaminants that exert their toxicity on different
mechanisms, such as binding to different receptors. Mixture effects
have been documented at concentrations below the experimental no
observed adverse effect levels for single contaminants [2].
In recent years there has been increasing focus on the content of
agricultural pesticides in aquaculture feeds. Limited availability of
marine raw materials has forced the feed producers to increase the
inclusion of plant ingredients in the products [3]. National monitoring
programs have documented the presence of the organophosphorus
pesticides chlorpyrifos-methyl (CPM) and pirimiphos-methyl (PPM) in
5–20 % of screened Norwegian Atlantic salmon feeds [4,5]. In 2018, the
CPM and PPM concentrations ranged from 13 to 30 μg/kg and 9 to 19
μg/kg, respectively [5]. Vegetable oils are the most likely source of
these pesticides in the commercial feeds. Organophosphorus pesticides
act primarily by inhibiting acetylcholinesterase (AChE) in nerve cells
[6]. Secondarily, mechanisms associated with oxidative stress, im-
munotoxicity, endocrine disruption, neurotoxicity, and neurobehavior
may be affected [7–10]. In addition to the active ingredient, pesticide
formulations also contain adjuvants included to improve the solubility
or the compatibility of the principal ingredient [11]. It is well docu-
mented that adjuvants may affect the bioavailability [11] and toxicity
of pesticides [12,13]. Risk assessment of pesticide formulations should
therefore also include adjuvants [14].
Internationally, nonylphenol ethoxylates (NPE) are among the most
frequently used industrial surfactants [15,16]. NPEs are easily
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biodegraded, and some of their lipophilic metabolites such as non-
ylphenol (NP) are more persistent in the environment than the mother
substance [17]. NPE metabolites have been detected in soybeans and
maize products [18], as well as in fatty tissue of fish and other organ-
isms [19]. Alkylphenols like nonylphenol (NP) are xenoestrogens and
acts as endocrine disruptors [20], and can be very toxic to aquatic or-
ganisms [16]. The European Union has banned the production of NP
and NPE due to their impacts on human health and the environment
[15]. In the US, EPA is reviewing its use, while in Asian and South
American countries NP is still widely available [16].
As part of seafood safety assessments, we have been studying the
toxic effects of feed-borne contaminants in fish. In liver cells of Atlantic
salmon, perturbation of lipid metabolism is one of the main secondary
effect of organophosphorus pesticides such as chlorpyrifos (CPF), CPM
and PPM. We have shown that exposure to these compounds leads to
accumulation of lipids and disrupted cholesterol biosynthesis in liver
cells [21–28]. The mixture effects were mainly additive at low con-
centration and synergistic at higher concentration [21]. Furthermore,
there is a lack of knowledge about how pesticide adjuvants affect the
toxicity of CPM and PPM in fish. We selected NP as a model adjuvant
with known toxic effects in fish. Despite being banned in the EU and
being phased out as pesticide adjuvant and industrial surfactant, NP-
based products are still in use in many countries. NP has been found in
drainage water from agricultural areas and represent an environmental
challenge in some countries from where the feed producers obtain their
ingredients [29,30]. NP is a ubiquitous pollutant and may be present in
fish feed independent of its use in pesticide formulations. We have
detected NP above the detection limit in experimental control fish feed
(unpublished data). It is therefore very relevant for mixture toxicity
assessments of feed-borne contaminants. The aim of this study was
therefore to perform a mixture toxicity evaluation of CPM, PPM and NP
in Atlantic salmon liver cells.
2. Material and methods
2.1. In vitro exposure experiment
Hepatocytes were harvested with a two-step perfusion method from
male Atlantic salmon (Salmo salar) (n= 6, mean± st.dev.: 1.10±0.32
kg). After cell extraction, cell viability was 95± 1% (Trypan Blue, n =
6, mean± st.dev). Cells were cultured for 36−40 hours prior to ex-
posure in L-15 medium, with change of medium after 18−20 hours.
Hepatocytes used for lipidomics, gene expression (RT-qPCR) and the
MTT assay were plated on laminin-coated (2 μg/cm2) 3D culture plates
with Alvetex scaffolds (200 μm cross-linked polystyrene membranes, 42
μm mean void size, Reprocell, Glasgow, UK) or 96 2D xCELLigence
plates. Cells were exposed in 12-well plates (lipidomics and for RT-
qPCR), or in 96-well plates (cytotoxicity determination with MTT and
xCELLigence). The following cell densities were used, 2.9 × 106 cells
per well for lipidomics and RT-qPCR, and 0.2 × 106 cells per well for
cytotoxicity screening. The exposure medium was changed after 18−20
hours. Cell harvesting and treatment are described in detail by
Søfteland et al. [31]. The use of 3D culture plates with Alvetex scaffolds
has been described in toxicity testing earlier by others [32,33].
Dose-response relationships were established for assessment of cy-
totoxicity and gene expression, using 0, 0.1, 1.0, 10, 100 and 1000 μM
CPM, PPM and NP. For evaluation of mixture toxicity, the cells were
exposed to the three chemicals using a factorial design with con-
centrations of 1, 50.5 and 100 μM as outlined in Table 1. CPM, PPM and
NP were dissolved in dimethyl sulfoxide (DMSO) (Scientific and Che-
mical Supplies Ltd, Bilston, UK). All exposure solutions contained
equimolar concentration of DMSO (0.2 %). The number of biological
replicates was n = 5 for lipidomics and gene expression, and n = 6 for
cytotoxicity screening. Chemicals were obtained from Sigma-Aldrich
unless otherwise noted (Oslo, Norway).
2.2. Cytotoxicity screening
Cell viability was assessed with the MTT tetrazolium assay ac-
cording to the manufacturer’s protocol (In Vitro Toxicology assay kit,
Sigma Aldrich). After the 48 -h treatment period, MTT substrate was
added to the cell cultures. After 4 -h incubation, the number of viable
cells was measured by recording changes in absorbance at 570 nm using
a Labsystem iEMS microplate reader (Labsystems iEMS Reader MF,
Helsinki, Finland). Cytotoxicity was also assessed with the impedance-
based real-time xCELLigence system (Real-Time Cell Analyzer RTCA-
SP, ACEA Biosciences, San Diego, USA) [34]. Cell index (CI) values and
normalization was recorded using the RTCA Software. Real-time mon-
itoring of cell viability was performed in an incubator at 10 °C without
O2/CO2 supplementation with the RTCA single plate xCELLigence
platform.
2.3. RNA isolation and RT-qPCR
Total RNA was extracted from hepatocytes cultured in Alvetex
scaffold plates as described by the Reprocell protocol (Reprocell,
Glasgow, UK) using the RNeasy Plus mini kit (Qiagen, Crawley, UK). In
brief, cells were washed with PBS and lysed by adding 600 μL Qiagen
RNeasy Plus mini kit lysis buffer RLT per well and placed for 10 min on
a rotating platform (100 rpm) at room temperature. The lysate was
homogenized 10 times with a 20-gauge needle. 600 μL 70 % ethanol
was added to the homogenized lysate. A pipette was used to mix the
sample 10 times before transfer to a collection tube and stored at −80
°C. The samples were transferred to RNeasy® spin columns. A DNase
digestion on-column was performed before finalizing the RNeasy Plus
mini kit protocol. RNA was eluted in 30 μL RNase-free MilliQ H2O and
stored at −80 °C. The NanoDrop ND-1000 UV–vis Spectrophotometer
(NanoDrop Technologies, Wilmington, DE, USA) and the Agilent 2100
Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA) were used to
check RNA quality. RNA integrity was evaluated with the RNA 6000
Nano LabChip kit (Agilent Technologies, Palo Alto, CA, USA). The mean
RNA integrity number (RIN) of 12 randomly selected samples used for
RT-qPCR was 10.0± 0.0 (mean± st.dev.).
A two-step real-time RT-qPCR protocol was used to quantify the
transcriptional levels of 11 target genes and potential 3 reference genes
(see Table S1 for PCR assays). A normalization factor based upon actb
and eef1a1 (M<0.42) was used to calculate mean normalized
Table 1
Factorial design applied to evaluate mixture toxicity.
The samples marked gray are part of the fractional factorial design used for the
lipidomic analysis.
P.A. Olsvik and L. Søfteland Toxicology Reports 7 (2020) 547–558
548
expression (MNE) of the target genes [35].
2.4. Lipidomics profiling
Harvesting of cells cultured in Alvetex scaffolds for the metabo-
lomics analysis were performed according to the Reprocell protocol
(Reprocell, Glasgow, UK). In brief, 3D hepatocytes were washed with
PBS. The hepatocytes were incubated with 1.5 mL 0.25 % trypsin for 15
min on a rotating platform (100 rpm) at room temperature. 2 mL
complete medium was used to stop the trypsin reaction. The cell sus-
pension was transferred to centrifugation tubes and centrifuged at
1000×g for 5 min at 4 °C. The supernatant was discharged, and the
cells were dissolved in 2 mL PBS and wasted a second time at 1000 × g
for 5 min at 4 °C. Cells from three 12-well plate wells were pooled. Cells
and medium were flash frozen and stored at −80 °C.
The lipidomics analysis was conducted by Metabolon (Metabolon,
Research Triangle Park, NC, US) as earlier described by Zhang et al.
[36]. In brief, lipids were extracted from samples using a modified
Bligh-Dyer extraction in the presence of internal standards. Infusion-MS
analyses were performed with a SelexION equipped Sciex 5500 QTRAP
using both positive and negative mode electrospray. Each sample was
analyzed twice, with IMS-MS conditions optimized for lipid classes
monitored in each analysis. The 5500 QTRAP was operated in MRM
mode to monitor the transitions for over 1100 lipids from up to 14 lipid
classes. Individual lipid species were quantified based on the ratio of
signal intensity for target compounds to the signal intensity for an as-
signed internal standard of known concentration. Lipid class con-
centrations were calculated from the sum of all molecular species
within a class, and fatty acid compositions were determined by calcu-
lating the proportion of individual fatty acids within each class.
2.5. Statistics
One-way and two-way ANOVA with Holm-Sidak’s posttest were
used for statistical analyses of the cytotoxicity and gene expression data
(GraphPad Software, San Diego, CA, USA). The Surveyor software was
used to analyze the lipidomics data using complex lipid panels
(Metabolon, Research Triangle Park, NC, USA). To meet the assumption
of homogeneity of variance, the data were log-transformed if deemed
necessary before ANOVA analysis. For the lipidomics data, log-trans-
formed differential composition values were used in all calculations.
Principal component analysis (PCA) and PLS regression were used for
multivariate analyses. Design of the experiment and PLS analysis was
conducted with the MODDE software (Umetrics, Umeå, Sweden).
Before PLS analysis the blend matrix was strengthened with interaction
terms for the cytotoxicity and RT-qPCR data, but not for the lipidomics
data for which a fractional factorial design was used. The PLS data were
scaled to unit variance and mean centered. Finally, PLS model valida-
tion was ensured with respect to the explained variance and goodness of
prediction (Q2), and with respect to goodness of fit (R2) [37].
3. Results
3.1. Nonylphenol acted cytotoxic
Of the three examined compounds, only NP significantly reduced
cell viability at the tested concentration range (Fig. 1). According to the
MTT cytotoxicity data, 1000 μM NP reduced viability with 79 %
(Fig. 1A), while the xCELLigence system, which measure impedance
and how tightly the cells are bound to the gold-plated wells, showed a
69 % reduction in viability at 1000 μM NP (Fig. 1B). No cytotoxicity
was seen up to 1000 μM for CPM and PPM (Fig. 1C–F), or for 100 μM of
any of the compounds (the concentration used for the mixture toxicity
assessment). The xCELLigence data indicated a stimulation effect at 100
μM for cells exposed to all three compounds, i.e. an improvement of
their ability to bind to the substrate in the 96-well exposure plates. A
multivariate PLS model, based on 54 log-transformed xCELLigence
normalized cell index (NCI) values (9 mixture combinations and 6 fish,
see Table 1), was applied to analyze the cytotoxicity data. The PLS
model indicated a synergistic interaction on the cell viability reduction
caused by PPM and NP at high concentrations (Fig. 1G).
3.2. Transcriptional effects on lipid metabolism, estrogenic, and
detoxification markers
3.2.1. NP gave the strongest dose-response effects
Based on known markers for lipid metabolism (fabp3, d5d (fads1),
d6d (fads2), ptgs2, srebf2, scd), endocrine disruption (vtg, esr1, zp3),
oxidative stress (cat), growth and apoptosis (igf1), and detoxification
(cyp1a, cyp3a, gsta1, ugt1a, sult3), selected genes were examined with
RT-qPCR. For the lipid metabolism markers (Fig. 2), PPM at 100 and
1000 μM significantly up-regulated fabp3 (Fig. 2C). Of the two delta
desaturases, d5d and d6d were significantly down-regulated in cells
exposed to 100 μM NP (Fig. 2D–G). NP further significantly up-regu-
lated ptgs2 at 100 and 1000 μM (Fig. 2J). Finally, srebf2 and scd were
significantly down-regulated at the two highest exposure concentra-
tions by NP (Fig. 2M–P), while the other two compounds had no effects
on their expression.
Of the estrogenic markers, vtg was significantly induced by NP (> 1
μM), PPM (>10 μM) and CPM (>100 μM) (Supplementary file 1, Fig.
S1). For NP and PPM, vtg showed the strongest induction at inter-
mediate exposure concentrations (NP: 10 μM, PPM: 100 μM) (Fig.
S1A–C). Compared to the control, esr1 was significantly down-regulated
by NP at 1000 μM, and significantly up-regulated by PPM at con-
centrations above 10 μM (Fig. S1D–F). The marker for growth and
apoptosis, igf1, responded significantly only to NP treatment (up-
regulated by 1000 μM NP) (Fig. S1J–L). Cat, included as a marker of
oxidative stress, only showed a significant response in cells exposed to
the highest NP dose (Fig. S1M–O). For the detoxification markers
(Supplementary file 1, Fig. S2), significant responses were seen for
cyp1a in cells exposed to PPM (up-regulated by 10 and 100 μM) (Fig.
S2C), for cyp3a in cells exposed to NP (down-regulated by 100 and 1000
μM) (Fig. S2D) and for ugt1a in cells exposed to NP (up-regulated by
1000 μM) (Fig. S2 J).
3.2.2. Interaction effects for eight transcripts
Multivariate PLS interaction assessment was performed using a
factorial design and the transcriptional levels of 13 candidate bio-
markers (fabp3, d5d, d6d, ptgs2, scd, srebf2, vtg, esr1, cat, igf1, cyp1a,
cyp3a, ugt1a). The three genes which showed no significant dose-re-
sponse effects, gsta1, sult3 and zp3, were not subjected to multivariate
analysis. Using MNE data, PLS regression models based on 45 log-
transformed values (9 mixture combinations and 5 fish) were used to
search for interaction effects between the three compounds at 1, 50.5
and 100 μM. According to the PLS models, significant effects were
observed for 8 of the 13 target genes (Table S2). In all PLS models, NP
had the strongest effect on the transcriptional levels compared to the
other treatments. Significant interaction effects between CPM and PPM
were observed for three lipid metabolism genes (d5d, d6d and scd). The
contour plots indicated antagonistic interactions at low concentrations
and synergistic interactions at high concentrations of the pesticides
with downregulation of d5d (Fig. 3A) d6d (Fig. 3B) and scd (Fig. 3C),
which turned only antagonistic for d6d and scd, with increasing NP
concentration. No significant interaction terms were seen for srebf2
(Fig. 3D).
The PLS models for two estrogenic markers and two detoxification
markers were also significant (Fig. S3). For esr1, the PLS model in-
dicated an antagonistic effect between PPM and CPM at all NP con-
centrations (Fig. S3A), while for vtg the model indicated both antag-
onisms and synergism over the NP concentration gradient (Fig. S3B).
No significant combined effects were seen for cyp1a (Fig. S3C), while
for ugt1a the model indicated a synergism and antagonism effect (Fig.
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Fig. 1. A-F) Dose-response-dependent cyto-
toxicity of chlorpyrifos-methyl (CPM), pir-
imiphos-methyl (PPM) and nonylphenol (NP)
in Atlantic salmon hepatocytes determined
with the MTT assay and the xCELLigence
system. G) Simplified scaled and centered PLS
regression coefficients with 95 % confidence
intervals (upper figure) and contour plots
(lower figure) based on normalized cell index
(NCI) cytotoxicity (factorial design of
xCELLigence data). The model contained one
PLS component (R2 = 0.31 and Q2 = 0.10).
The highlighted values in the contour plots
represent NCI levels for the different stratifi-
cation beddings (isoboles). The model was
significant (regression: p = 0.001), with sig-
nificant coefficients for NP (p = 0.0006) and
PPM*NP (p = 0.0078) and showed a sy-
nergistic interaction between PPM and NP.
Note, for the contour plots, blue color reflects
the strongest effect with strongest reduction in
NCI. (For interpretation of the references to
colour in this figure legend, the reader is re-
ferred to the web version of this article).
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Fig. 2. Dose-response relationships of genes associated with lipid metabolism in Atlantic salmon hepatocytes exposed to nonylphenol, chlorpyrifos-methyl and
pirimiphos-methyl for 48 h. A-C) fabp3, D-F) d5d, G-I) d6d, J-L) ptgs2, M-O) srebf2, and P-R) scd. MNE = mean normalized expression. Asterisk’s denote significance
based on one-way ANOVA analyses, with Holm Sidak’s posthoc test. N = 3–5. * p<0.05 (exact p-values given in figure), ** p<0.01, *** p<0.001, ****
p< 0.0001. Mean±SEM.
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S3D). The interaction effect for cat indicated a synergism and antag-
onism effect with increasing NP concentration (Fig. S3E). The sy-
nergistic and the antagonistic interaction on the down-regulation of
these markers, caused by the pesticides, had an equal contribution to
the mixture toxicity as the negative impact of NP.
3.3. Phospholipids and triacylglycerols (TAGs) distinctly affected by CPM,
PPM and NP
The number of lipid species detected in the hepatocyte culture
samples used for dose-response assessment and fractional factorial de-
sign varied between 676 and 925 (n = 60, 870± 78 mean± st.dev.).
In total, the platform could quantify the concentration of 928 lipid
metabolites. Total concentrations of each lipid class and mean differ-
ence relationships are shown in Supplementary file 2. The mean dif-
ference figures show significant lipid species separated by lipid class
based on pairwise comparisons to the control for 1 and 100 μM CPM,
PPM and NP, as well as for the cells treated with 100 μM of all three
compounds. Table 2 shows a summary of the main effects on the dif-
ferent lipid classes. In brief, the three compounds had a distinct effect
on a few free fatty acids and strongly affected phospholipids and TAG.
While all three compounds reduced the total levels of phosphatidy-
lethanolamine (PE) in the cells, exposure to CPM and NP increased the
total levels of phosphatidylcholine (PC), whereas PPM resulted in de-
creased PC levels. Most surprisingly, although exposure to all three
compounds alone (100 μM) resulted in accumulation of total TAG in the
cells, combined exposure to 100 μM of all three compounds resulted in
reduced total TAG level. Total TAG concentration dropped from 96.2
μM in the control to 63.7 μM in the co-treatment group (p = 0.042).
This drop is illustrated for the five most strongly down-regulated TAG-
FA18:1 species by the combined treatment in Fig. 4. For ∑TAG accu-
mulation, 2-way ANOVA analysis showed a significant interaction ef-
fect between 100 μM PPM and the combined treatment groups
(p<0.0001), suggesting that PPM interfered with the degree of TAG
accumulation in cells given a combination of all three compounds.
TAGs bound to the saturated fatty acids palmitic acid (TAG-FA16:0)
and oleic acid (TAG-FA18:0n-9), the monounsaturated fatty acids pal-
mitoleic acid (TAG-FA16:1n-7), octadecaenoic acid (TAG-FA18:1n-9),
and eicosenoic acid (TAG-FA20:1n-9), and the polyunsaturated fatty
acids (PUFAs) linoleic acid (TAG-FA18:2n-6), eicosapentaenoic acid
(EPA) (TAG-FA20:5n-3) and docosahexaenoic acid (DHA) (TAG-
FA22:6n-3) were strongest affected by the studied compounds. Reduced
levels of TAG were mirrored by reduced levels of diacylglycerol (DAG),
a response most strongly driven by NP exposure. Table 3 shows the
most significantly affected lipid species in cells treated with 100 μM of
the three compounds. In terms of fold-change, NP had the strongest
Fig. 3. PLS models for lipid marker genes in chlorpyrifos-methyl (CPM), pirimiphos-methyl (PPM) and nonylphenol (NP) exposed Atlantic salmon hepatocytes.
Simplified scaled and centered PLS regression coefficients with 95 % confidence intervals (upper figure) and contour plots (lower figure) based on mean normalized
expression (MNE) (factorial design of RT-qPCR data). The model contained one PLS component. The highlighted values in the contour plots represent MNE levels for
the different stratification beddings (isoboles). A) d5d, regression: p = 0.030, R2 = 0.23 and Q2 = 0.09, with significant coefficients for NP (p = 0.0100) and
PPM*CPM (p = 0.036) and a synergistic and antagonistic interaction between PPM and CMP. B) d6d, regression: p = 0.000, R2 = 0.47 and Q2 = 0.22, with
significant coefficients for NP (p = 0.0000) and PPM*CPM (p = 0.0007) and antagonistic interaction between PPM and CMP. C) scd, regression: p = 0.000, R2 =
0.45 and Q2 = 0.2, with significant coefficients for NP (p = 0.0002) and PPM*CPM (p= 0.011) and antagonistic and synergistic interaction between PPM and CMP.
D) srebf2, regression: p = 0.003, R2 = 0.33 and Q2 = 0.2, with significant coefficients for NP (p = 0.0002) and no combined effect.
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impact on the lipids.
Fig. 5 shows complex lipid pathways and maps in Atlantic salmon
hepatocytes exposed to 100 μM CPM (Fig. 5A), 100 μM PPM (Fig. 5B),
100 μM NP (Fig. 5C) and a combination of 100 μM of all three com-
pounds (Fig. 5D). Among the most distinct effect of CPM, PPM and NP
alone and in combination was the impact on saturated cholesteryl ester
(elevated 16:0), and monounsaturated cholesteryl ester (reduced 20:1).
NP alone also profoundly increased lysophosphatidylcholine (LPC) and
lysophosphatidylethanolamine (LPE) (18:0), and reduced phosphati-
dylinositol (PI), PE and free fatty acid (FFA18:1). Combined treatment
elevated the levels of 18:0-bearing species and declined the levels of
18:1 species. Phosphatidylinositol (PI), lysophosphatidylcholine (LPC),
lysophosphatidylethanolamine (LPE), and PE were the most strongly
increased saturated lipid species (18:1) (in that order), while phos-
phatidylinositol (PI), lysophosphatidylethanolamine (LPE), and free
fatty acid were the most strongly reduced saturated lipid species.
For lipid species, a fractional factorial design was used to search for
associations between the three compounds. A total of 48 lipid species
were selected for multivariate analysis. These included the 10 most
significantly affected lipid species obtained from the dose-response re-
lationship assessment (at 100 μM), as well as all free fatty acids. Of the
14 lipid species for which the PLS regression model was significant
(Table S3), most changes were caused by one chemical except for four
lipids where two or three of the chemical contributed to the observed
responses; FFA (22:5) (Fig. 6A), LPC (18:0) (Fig. 6B), TAG52:1-FA 16:0
(Fig. 6C), and TAG52:1-FA 18:0 (Fig. 6D). Based on the linear terms,
only LPC (18:0) was affected by all three chemicals co-acting to in-
crease LPC levels.
4. Discussion
This study shows how an adjuvant with endocrine-disrupting
properties may influence the toxicity of organophosphorus pesticides in
fish cells. NP most distinctly affected the degree of total TAG accu-
mulation in cells co-treated with CPM and PPM in Atlantic salmon
hepatocytes. While NP, CPM and PPM (100 μM) alone all resulted in
increased accumulation of ∑TAG, combined treatment had the opposite
effect. Short-term exposure to CPF/CPM typically leads to accumulation
of monoacylglyceride (MAG) and reduced levels of many PUFAs
[21,23,26], whereas PPM increases the levels of diHOME fatty acids
and cholesterol and decreases lysophospholipid metabolism in salmon
hepatocytes [24]. In this study, using a lipidomics pipeline that did not
analyze individual MAGs, combined treatment showed that PPM and
CPM contributed to the reduced levels of palmitic acid-TAG (TAG 52:1-
FA 16:0) and stearic acid-TAG (TAG 52:1-FA 18:0). However, only NP
contributed to the reduction of TAG (50:1-FA 16:0) in co-exposed cells.
Taken together, mixture toxicity assessments are of major importance
to understand how these chemicals together affect accumulation of li-
pids in the cells.
Exposure to persistent organic pollutants (POPs) and especially
endocrine disruptors is often associated with accumulation of fat in the
liver [38]. Polyethoxylated tallow amines, adjuvants used in glypho-
sate-based herbicide formulations, and nonylphenol ethoyxlate surfac-
tants, can all induce TAG accumulation in mice adipocytes [39]. Ex-
cessive accumulation of lipids in the liver has been suggested to be one
of the most pathologically recognized responses to chemical exposure
[40]. Fish studies indicate that mechanisms associated with excessive
synthesis and accumulation of TAG are conserved across phyla [41,42].
In this study, we observed a synergistic interaction between NP and
PPM on cell death, and that both NP and PPM reduced total TAG at 1
μM, suggesting that NP and PPM most profoundly affected lipid accu-
mulation.
Combined treatment resulted in a general pattern of elevated levels
of saturated fatty acids and a declined level of monounsaturated fatty
acids. In particular, the increased levels of 18:0-bearing species across
all classes and reduced levels of 18:1 species for most classes, was more
pronounced in cells co-treated with all three compounds. Reduced le-
vels of 18:1 species suggests an inhibition of stearoyl CoA desaturase
(SCD), an enzyme responsible for endogenous biosynthesis of mono-
unsaturated fatty acids, i.e. palmitoleic acid (16:1n-7) and oleic acid
(18:1n-9), giving rise to a mixture of 16:1 and 18:1 unsaturated fatty
acids [43]. In support, exposure to the mixture of all three compounds
resulted in reduced transcriptional levels of scd. As palmitoleic acid and
oleic acid are major components of membrane phospholipids, inhibited
Table 2
Summary of lipid effects. Chlorpyrifos-methyl (CPM), pirimiphos-methyl (PPM)
and nonylphenol (NP). Neutral lipids: FFA = free fatty acid, DAG = dia-
cylglycerol, TAG = triacylglycerol. Phospholipids: PC = phosphatidylcholine,
PE = phosphatidylethanolamine, LPC = lysophosphatidylcholine. ↑ = in-
creased 1-10-fold, ↑↑ = increased> 10-fold, ↓ = decreased 1-10-fold, ↓↓ =
decreased> 10-fold.
Treatment 1 μM 100 μM
CPM FFA(16:0) ↑ FFA(18:1) ↓
PC(16:0/22:6) ↑ ∑PC ↑
∑TAG ↑ ∑PE ↓
∑TAG ↑↑
PPM ∑PC ↓ ∑PC ↓
∑PE ↓ ∑PE ↓
∑TAG ↓ ∑TAG ↑↑
NP ∑PC ↑ ∑DAG ↓
∑PE ↓ ∑PC ↑↑
∑TAG ↓ ∑PE ↓↓
∑TAG ↑






Fig. 4. Total concentration of five TAG(FA18:1) lipid species (TAG50:2-FA18:1,
TAG52:2-FA18:1, TAG52:3-FA18:1, TAG54:3-FA18:1 and TAG56:4-FA18:1) in
Atlantic salmon hepatocytes exposed to 100 μM chlorpyrifos-methyl (CPM),
100 μM pirimiphos-methyl (PPM), 100 μM nonylphenol (NP) and a combina-
tion of 100 μM of all three compounds. N = 5. Mean± SEM. **p<0.01.
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SCD activity may affect membrane permeability and fluidity. A distinct
reduction of PE and increase of PC, the most common phospholipids in
fish membranes [44], by CPM, NP and combined treatment emphasizes
that membrane phospholipids are one of the main targets of the studied
compounds and in particularly of NP. Long-term in vivo studies also
point to effects of organophosphorus pesticides on phospholipids. We
observed a significant reduction in arachidonic acid (ARA, 20:4n-6) and
increased content of the saturated fatty acid palmitic acid (PA, 16:0)
with increasing dietary content of CPM in liver of Atlantic salmon [28].
Up-regulation of ptgs2, of which the encoded protein COX2 converts
ARA to prostaglandin H2 [45], indicates an inflammatory effect at 100
and 1000 μM NP, a response not seen for CPM and PPM, and an effect
on membrane phospholipids in this study. The significant elevated le-
vels contributed by PPM and NP seen for free fatty acid doc-
osapentaenoic acid (DPA, 22:5) could be linked to differential expres-
sion of ptgs2, as DPA acid has been shown to affect the expression of
PTGS2 protein in rat cells [46]. NP alone strongly increased PC (FA
16:0), PC (FA 18:0) and PC (FA 22:6), and reduced PE (FA 18:1) and PE
(FA 22:6). PE, together with fatty acid desaturation and cholesterol, is a
key regulator of membrane fluidity in most eukaryotic cells [47]. Al-
tered levels of PC and PE could also be associated with increased in-
corporation of excess intracellular fatty acids into TAGs stored in cy-
tosolic lipid droplets which are surrounded by a monolayer of
phospholipids [48]. Furthermore, an impact on membrane fluidity was
suggested by the reduced transcriptional levels of srebf2 by NP and that
in combined treatment only NP contributed to the down-regulation
seen for this gene. Srebf2, encoding SREBP2, is a transcription factor
that regulates the synthesis and cellular uptake of cholesterol and fatty
acids, two major constituents of cell membranes [49]. Lysopho-
sphatidylcholine (LPC 18:0) was the only lipid species that showed a
significant increase that was caused by all three compounds in co-ex-
posed cells. Lysophosphatidylcholine (LPC 18:0) is a membrane lyso-
phospholipid found in small amounts in most tissues [50] that has a role
in lipid signaling by acting on lysophospholipid receptors and it also
acts as a membrane stabilizer. Interestingly, lysophosphatidylcholine
(LPC 18:0) has an industrial application as a surfactant and emulsifier
[50]. Based on the lipid signature equations, fatty acid synthase (FASN)
activation was only predicted for the combined treatment. The function
of FASN is mainly to catalyze the synthesis of palmitoleic acid from
acetyl-CoA and malonyl-CoA into long-chain saturated fatty acids [51].
FASN activation again points to effects on mechanisms associated with
the degree of unsaturation (number of double bonds) and membranes
[52,53]. According to the lipidomics data, NP contributed most strongly
to SCD inhibition, but CPM and PPM antagonized the reduction. While
all three compounds reduced the total levels of PE in the cells, exposure
to CPM and NP increased the total levels of PC, whereas PPM resulted in
decreased PC levels. The transcriptomic data also suggested that this
was mainly a response to NP exposure, as scd was down-regulated by
100 and 1000 μM NP but not by the two organophosphorus pesticides.
In zebrafish, it had been shown that CPF upregulate scd [54], indicating
that the studied compounds act differently on this gene. It is well es-
tablished that cell membranes and phospholipids are among the main
targets of agricultural adjuvants in animals [55,56]. In our earlier re-
search, we have documented this to be true for CPM and PPM in
Atlantic salmon hepatocytes [25,28]. In this study, we show that NP
acts by disrupting phospholipid metabolism by reducing the levels of PE
and increasing the levels of PC and phosphatidylinositol (PI). This effect
was less pronounced in co-treated cells, again suggesting a different
mechanistic effect of the studied compounds on phospholipids.
One of the novel lipidomics findings in this study was the predicted
dysregulation of D6D activity in cells treated with a combination of all
three compounds, a response not seen in separately treated cells.
Additionally, significant interaction effects were observed for all of the
desaturase genes (d5d, d6d, and scd). D6D, together with D5D, are key
enzymes in endogenous production of long-chain PUFAs (n-3 and n-6
PUFAs) from monounsaturated fatty acids [57]. All three compounds
alone resulted in reduced levels of very-long chain fatty acids, a re-
sponse not seen in co-treated cells. At the transcriptional level, d6d (and
d5d) was down-regulated by NP at 100 μM, but not at 1000 μM.
Treatment with CPM and PPM did not significantly affect d6d tran-
scription. We have previously seen a reduced transcription of d6d in
Atlantic salmon liver cells exposed to 1000 μM PPM [24], a finding not
replicated in the current study. We have generally noticed that 3D cell
cultures are less responsive (i.e. better protected) than 2D cell cultures
to external stimuli, possibly explaining the contradicting result. Dietary
fat content as well as many POPs are known to modify d6d expression in
fish. For example, transcriptional down-regulation has been reported in
Javanese medaka (Oryzias javanicus) exposed to bisphenol A [58] and in
zebrafish (Danio rerio) larvae exposed to 2,2',4,4'-tetrabromo diphenyl
ether (PBDE) [59]. In an earlier study, we found a significant interac-
tion effect between dietary lipid composition (high fish oil versus high
plant oil content) and MeHg for d5d but not for d6d transcription in
Atlantic salmon liver after prolonged exposure [60], further empha-
sizing an association between contaminant exposure and effects on
Table 3
The most significantly changed lipid species in Atlantic salmon liver cells treated with 100 μM chlorpyrifos-methyl (CPM), pirimiphos- methyl (PPM) and non-
ylphenol (NP).
Treatment (100 μM) Up-regulated Fold-change P-value Down-regulated Fold-change P-value
CPM TAG58:6-FA22:5 2.36 < 0.001 CE(24:1) −2.46 0.018
TAG56:5-FA22:5 2.26 0.008 PE(P-18:0/18:0) −2.28 <0.001
TAG56:8-FA20:5 2.24 0.023 FFA(22:6) −2.00 0.022
TAG56:9-FA20:5 2.18 0.042 PI(16:0/20:3) −1.82 0.022
TAG52:7-FA20:5 2.15 0.004 PE(18:1/18:2) −1.78 0.003
PPM TAG58:7-FA18:0 2.26 < 0.001 CE(24:1) −2.13 0.031
TAG58:7-FA22:6 2.17 < 0.001 PE(16:0/20:3) −1.27 0.029
TAG52:7-FA22:6 2.09 0.003 PC(18:1/20:3) −1.25 0.017
TAG58:6-FA18:0 2.04 < 0.001
TAG58:6-FA22:5 2.04 0.003
NP TAG58:6-FA18:0 5.12 < 0.001 PI(18:1/18:1) −2.78 0.003
TAG56:5-FA22:5 5.03 < 0.001 PC(12:0/20:3) −2.45 0.007
TAG56:6-FA22:6 5.00 < 0.001 CE(24:1) −2.43 0.015
TAG54:0-FA18:0 3.98 0.023 PE(18:1/20:4) −2.30 <0.001
TAG58:7-FA18:0 3.80 < 0.001 PE(18:1/22:5) −2.26 0.001
CPM + PPM + NP PI(18:1/18:2) 4.28 < 0.001 PI(18:1/20:3) −4.20 <0.001
LPC(18:0) 3.83 < 0.001 PI(18:1/20:4) −3.96 <0.001
PI(18:0/18:1) 3.08 0.004 TAG48:2−12:0 −2.81 0.035
LPC(22:5) 2.64 0.008 PC(12:0/18:1) −2.79 0.001
LPC(17:0) 2.57 0.003 TAG48:2-FA14:1 −2.70 0.017
P.A. Olsvik and L. Søfteland Toxicology Reports 7 (2020) 547–558
554
desaturase genes. The contour plots in this study showed an antag-
onistic effect of PPM and CMP at low concentrations and synergistic
effect at high pesticide concentrations on NP down-regulation of d5d
and antagonistic effect on NP down-regulation of d6d, suggesting that
potent estrogenic chemicals like NP at high concentrations may
strengthen the toxic effect of feed-borne organophosphorus pesticides
in salmon. D6D, encoded by d6d_a/b/c in Atlantic salmon [57], is also a
rate-limiting enzyme involved in the conversion of plant-based alpha-
linolenic acid (ALA, 18:3n-3) into longer chain n-3 PUFAs such as ei-
cosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA,
22:6n-3) [61]. Detrimental effects on D6D activity by feed-borne pes-
ticides may potentially be a challenge for the salmon industry, since this
enzyme is responsible for the conversion of dietary alpha-linolenic acid
into healthy PUFAs in salmonids. With the reduced inclusion of marine
ingredients in feed, the levels of EPA and DHA in Scottish and Nor-
wegian farmed salmon filet has dropped from an average of 2.7 g in
2006 to 1.4 g per 100 g fillet and 1.1 g per 100 g fillet in 2015 [62,63].
To keep the nutrition value of farmed salmon as high as possible, the
salmon’s innate capacity to produce n-3 PUFAs from 18:3n-3 is of
paramount importance for the aquaculture industry [61]. Follow-up in
vivo experiments will be required to determine whether pesticide-in-
duced impacts on D6D will affect fish health, and whether this will
occur at concentrations found in present-day fish feed.
As expected, the three compounds induced dose-response effects on
Fig. 5. Complex lipid pathway maps in Atlantic salmon hepatocytes exposed to A) 100 μM chlorpyrifos-methyl, B) 100 μM pirimiphos-methyl, C) 100 μM non-
ylphenol and D) a combination of 100 μM of all three compounds (generated with Metabolon’s Surveyor tool). Significance levels are based on mole percent data,
mean differences and log-transformed P-values (p<0.05).
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vtg and esr1, included in this study as transcriptomic markers for en-
docrine disruption in male fish [64]. For NP and PPM, the response
curves were non-monotonic, with strongest vtg induction at 10 μM for
NP and at 100 μM for PPM. In terms of estrogenicity, the range was
NP>PPM>CPM. NP is a chemical with a well-documented endo-
crine-disrupting potential in fish [65]. The findings for CPM and PPM
are in line with our previous in vitro studies, which have documented
that these compounds have relatively weak estrogenic activity in
Atlantic salmon liver cells [22–24,26]. After short-term waterborne in
vivo exposure, CPF has been shown to be able to induce VTG in male
zebrafish liver [66]. After prolonged dietary exposure, however, we
have not detected any sign of endocrine disruption by CPM in liver of
Atlantic salmon [25] or in Atlantic cod (Gadus morhua) [27]. In mice,
CPM is considerably less toxic than CPF [67], possibly explaining the
difference. This study also document mixture toxicity for these genes
between NP and the two organophosphorus pesticides. In Atlantic
salmon liver cells exposed to a contaminant mixture consisting of CPF,
it was shown that EPA had an antagonistic effect on vtg transcription
[22]. Taken together, these results suggest that mixture toxicity should
be considered when evaluating the toxic effect of adjuvants with es-
trogenic capacity in fish.
Based on both the transcriptomic and lipidomic examination, this
study clearly shows that NP is a stronger toxicant than CPM and PPM at
equimolar concentrations. In addition to the aforementioned genes, the
dose-response curves seen for igf1, cat, cyp3a and ugt1a illustrate a more
distinct response pattern for NP than for CPM and PPM. The increased
expression of igf1 by NP may be associated with elevated levels of ptgs2,
as the latter has been shown to induce this cytokine [68]. However,
overexpression of igf1 has been linked to numerous phenotypes and
pathways, including apoptosis, and could signal increased cell death by
1000 μM NP as indicated by the increased cytotoxicity in this group.
Somewhat surprisingly, NP did not affect cyp1a transcription. Xenoes-
trogens like NP are known to suppress total microsomal CYP content
due to inhibitory aryl hydrocarbon and estrogen receptor crosstalk
[69]. NP did however down-regulate cyp3a at 100 and 1000 μM, and
ugt1a was up-regulated by the highest NP concentration. We have
earlier observed increased cyp1a transcription at intermediate CPF
concentrations (10 μM) but not at higher concentrations (100 μM) after
in vitro exposure [21,23], a response not replicated with the less toxic
CPM in this study. Such inverted U-shape response curves for cyp1a, as
also suggested by the significant up-regulation of PPM at intermediate
concentrations in this study, has been documented earlier in zebrafish
after CPF exposure [70] and is often reported for endocrine disrupting
chemicals [71]. Receptor crosstalk and non-monotonic response curves
illustrate the complexity of mixture exposure assessments [72]. In terms
of detoxification mechanism, 3D cell cultures have been shown to offer
a few advantages over using 2D culture. For example, we have seen
expression of genes encoding drug transporters in Atlantic salmon 3D
cultures, a phenomenon not experienced using 2D cell cultures (un-
published work). Similar results have been reported by others. Breslin
and O’Driscoll [73] observed increased expression of a number of
proteins involved in cell survival, drug targeting and drug transporters
in 3D compared to 2D cultures using human breast cancer cell lines.
Reduced cytotoxicity using 3D culture compared to 2D cell culture has
also been reported for human monocytic leukemia cells [74], sug-
gesting that 3D cultures have a more robust defense against external
stressors.
The dose-response curve for cat suggests that NP induced oxidative
stress only at 1000 μM, while no significant effects were seen for the
two organophosphorus pesticides. We have earlier documented that
CPF and CPM induce oxidative stress in Atlantic salmon hepatocytes at
100 μM based on global metabolomics data, but not according to
changed gene expression (RNA-seq) [23,26], while PPM appears to be a
weak oxidant [24]. With significant interaction PLS models seen for
ugt1a and cat, this study clearly suggest that mixture toxicity should be
considered also for mechanisms associated with detoxification and
oxidative stress when studying organophosphorus pesticides and ad-
juvants with estrogenic potential.
In line with earlier findings [14], this study underlines the im-
portance of considering mixture toxicity when examining the potential
harmful effect of single pesticides. The main challenge for mixture
toxicity evaluations is to predict the effects of a combination of che-
micals based only on information for each compound individually, in-
cluding toxicological mechanism of action [75]. As we have docu-
mented earlier for CPM and PPM, these organophosphorus pesticides
mainly act antagonistic at low concentrations and synergistic at higher
concentrations. This finding is in agreement with earlier research
showing that cholinesterase inhibitors often act synergistically [76].
Furthermore, our study indicates that the pesticides, when given in high
concentration, act synergistically especially on secondary stress mar-
kers in the cells. This is notably distinct for the oxidative stress marker
cat. Interestingly, at 100 μM NP the contour plots for the two estrogenic
markers vtg and esr1 suggest an antagonistic effect at low CPM and PPM
concentrations. The down-regulation of these transcripts was severely
strengthened by NP (additive effect). This probably reflects that NP is a
much stronger xenoestrogen than the two organophosphorus pesticides.
For the lipids which showed significant combined effects, the three
chemicals were driving the response in the same direction for three
lipid species, while for FFA(22:5) the data suggested that only PPM and
NP were responsible for the increased FFA(22:5) levels observed in
Fig. 6. PLS models of four lipid species showing significant contribution in Atlantic salmon hepatocytes after exposure to chlorpyrifos-methyl (CPM), pirimiphos-
methyl (PPM) and nonylphenol (NP). Simplified scaled and centered PLS regression coefficients with 95 % confidence intervals based on lipid levels (fractional
factorial design). The model contained three PLS components. A) Free FA (22:5), regression: p = 0.0040, R2 = 0.55 and Q2 = 0.38, with significant coefficients for
PPM (p= 0.0030) and NP (p= 0.022). B) LPC (18:0), regression: p= 0.0000, R2 = 0.83 and Q2 = 0.69, with significant coefficients for PMM (p= 0.0013), CPM (p
= 0.0015), and NP (p = 398-006) C) TAG52:1-FA16:0, regression: p = 0.028, R2 = 0.42 and Q2 = 0.17, with significant coefficients for PPM (p = 0.0475), CPM (p
= 0.026), and D) TAG52:1-FA18:0, regression: p = 0.025, R2 = 0.43 and Q2 = 0.19, with significant coefficients for PPM (p = 0.0403), CPM (p = 0.0216).
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mixture exposed cells, whereas CPM acted differentially. Except for the
total level of PE, and TAG accumulation after combined exposure, our
data suggest that these compounds disrupt many mechanisms asso-
ciated with lipid metabolism in a similar way. Follow-up in vivo studies
should also use lower concentrations, as recent findings indicate that
long-term exposure to chemical mixtures of contaminants with similar
toxic action may induce adverse effects in animals even at doses below
their toxicological reference value [77,78]. Overall, this study shows
that even with compounds that only have partly overlapping mode of
action, mixture toxicity may lead to underestimation of the negative
health effects in risk assessment of feed-borne pesticides in farmed fish.
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